Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes - Trial NCT06331338
Access comprehensive clinical trial information for NCT06331338 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 130 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
National Taiwan University Hospital
Timeline & Enrollment
N/A
Feb 14, 2024
Dec 31, 2025
Primary Outcome
glycemic control (HbA1c)
Summary
Decision cycle for person-centered glycemic management is a new diabetes decision making .It
 is defined as a purposefully designed holistic care intervention .The goal is to improve the
 self-care behavior of patients with type 2 diabetes, thereby improving glycated hemoglobin
 levels and delaying the occurrence of complications.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06331338
Non-Device Trial